Opportunity

`

Chronic Wounds

Definition & Current situation

Chronic wounds fail to progress through the phases of healing in an orderly way and show no progress towards healing after 30 days.

Unmeet Need – E.g. Diabetic Foot Ulcer

Chronic Wounds

Incidence & Drivers

Annual incidence (2018)

7.5M
4.5M
4.0M

Main Drivers

foto-1
Aging
foto-2
Obesity
foto-3
Diabetes

Chronic Wounds

Market Size: CAGR 7.5%
$25B
Chronic wound market (2018)
$15B
Wound care management products per year
$2.4B
Therapeutical & Device market for current options per year
Key Players: Only provide palliative treatment

A growing market

  • In 2012 in the US alone, 6 million patients (2% of population) suffered from chronic wounds.
  • Chronic wound care costs exceed $50 billion per year (conservative estimate).
  • In 2012, the global wound care management market stood at $11.7 billion.
  • The projected 2021 worth of the wound care management market is $18.5 billion.
  • Demographic factors such as aging, diabetes, and obesity contribute to rapid market growth.
  • Key drivers include the Affordable Care Act and recent Center for Medicare and Medicaid Services proposals.

Potential customers

  • Trauma physicians, dermatologists, plastic surgeons, and treatment centers.
  • Medical device companies (potential distributors or licensees with established distribution channels).
  • Our wound patients (end users), that suffer from chronic wounds, diabetic foot ulcers, burns, or bedsores.
  • Insurance companies as payers in the value chain.

Problem and need

  • The cost of wounds is affected by prolonged and intensified treatment, as well as prolonged hospitalization and specialized treatment.
  • Chronic wounds can lead to serious infections, gangrene, and in the worst cases amputation.
  • Currently low rates of wound closure.
  • Rise in prevalence of chronic wounds, has led to an increased demand for management approaches and device platforms dedicated to wound-care.
  • Actual products continue to provide only palliative treatment: Patient mobility, quality of life and overall individual well being are not positively affected.
  • These issues call for a dramatic change of focus on improving the effectiveness of the wound healing process.

Value added

  • Trauma physicians, dermatologists, plastic surgeons, and treatment centers.
  • Medical device companies (potential distributors or licensees with established distribution channels).
  • Our wound patients (end users), that suffer from chronic wounds, diabetic foot ulcers, burns, or bedsores.
  • Insurance companies as payers in the value chain.
Effective
High Benefit
Customizable
Environmentally Friendly
Simple
Intellectual Property